Amicus Therapeutics, Inc.
FOLD
$6.83
$0.131.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 62.99% | 39.70% | 35.50% | 27.99% | 35.92% |
| Total Depreciation and Amortization | 8.56% | 24.08% | 44.32% | 69.04% | 47.38% |
| Total Amortization of Deferred Charges | -13.53% | -19.99% | -12.97% | -6.91% | -0.68% |
| Total Other Non-Cash Items | -8.04% | 10.19% | -8.73% | 20.77% | 17.76% |
| Change in Net Operating Assets | -106.17% | 45.49% | 38.50% | -115.40% | -20.34% |
| Cash from Operations | 50.95% | 82.70% | 66.91% | 36.11% | 58.52% |
| Capital Expenditure | 52.24% | 40.42% | 7.17% | -51.11% | -97.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.16% | -98.56% | -96.33% | 6.79% | 13.85% |
| Cash from Investing | -100.57% | -107.46% | -102.80% | -1.44% | 6.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.98% | -149,456.78% | -139,266.89% | -140,220.27% | -144,181.98% |
| Issuance of Common Stock | -73.60% | -20.21% | 129.06% | 1,101.57% | 2,294.62% |
| Repurchase of Common Stock | -22.91% | -36.09% | -37.59% | -42.68% | -55.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -49.58% | -49.58% | -- | -- |
| Cash from Financing | -91.70% | -77.35% | 99.82% | 887.68% | 926.44% |
| Foreign Exchange rate Adjustments | -163.86% | -138.46% | 223.13% | 130.70% | 143.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.41% | -92.99% | 92.26% | 165.64% | 200.64% |